Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Sun Pharma

Immunology

Immunology Today—March 18, 2026

This week’s Immunology update highlights regulatory progress, late-stage…

Endocrinology

Endocrinology Today—March 10, 2026

This week’s Endocrinology update highlights regulatory progress in osteoporosis…

Endocrinology

Endocrinology Today—November 18, 2025

Weekly Endocrinology update spotilighting regulatory developments, clinical…

Immunology

Immunology Weekly News - September 17th 2025

🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Neuroscience Today—March 25, 2026
Immunology Today—March 25, 2026
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026

Tags

AC Immune Behcet’s disease Bivamelagon Cardiac Rehab Cardiovascular Risk CGRP chronic disease prevention Clindamycin Clonazepam Committee for Medicinal Products for Human Use Competitive Intelligence Process Dermatomyositis Duchenne MD Duvakitug ESC2025 Exosome Vaccines GLP-1 Adjuncts GLP1 drugs healthcare tech hospital technology IDT Biologika IgG4 Related Disease iMerit KRAS Lifileucel Macular degeneration Mantle Cell Lymphoma MDR-001 med tech Medtronic Diabetes Metformin Microplastics microRNA neurosymbolic AI Nutrition Science Parkinson’s Disease Apathy pediatric rare disease RelabotulinumtoxinA robotic surgery RRMS Serbian SCAD Registry Sjögrens Disease Sonelokimab Tabelecleucel thrombosis

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Neuroscience Today—March 25, 2026
Immunology Today—March 25, 2026
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026

TAGS

AC Immune Behcet’s disease Bivamelagon Cardiac Rehab Cardiovascular Risk CGRP chronic disease prevention Clindamycin Clonazepam Committee for Medicinal Products for Human Use Competitive Intelligence Process Dermatomyositis Duchenne MD Duvakitug ESC2025 Exosome Vaccines GLP-1 Adjuncts GLP1 drugs healthcare tech hospital technology IDT Biologika IgG4 Related Disease iMerit KRAS Lifileucel Macular degeneration Mantle Cell Lymphoma MDR-001 med tech Medtronic Diabetes Metformin Microplastics microRNA neurosymbolic AI Nutrition Science Parkinson’s Disease Apathy pediatric rare disease RelabotulinumtoxinA robotic surgery RRMS Serbian SCAD Registry Sjögrens Disease Sonelokimab Tabelecleucel thrombosis

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy